Hypomethylated and hypermethylated profiles of H19DMR are associated with the aberrant imprinting of IGF2 and H19 in human hepatocellular carcinoma

被引:61
作者
Wu, Jing [1 ,2 ]
Qin, Yang [1 ,2 ]
Li, Bo [3 ]
He, Wen-zhi [1 ]
Sun, Zhi-lin [1 ]
机构
[1] W China Med Ctr, Sch Preclin & Forens Med, Dept Biochem & Mol Biol, Chengdu 610041, Sichuan Prov, Peoples R China
[2] Sichuan Univ, State Key Lab Biotherapy, Chengdu 610041, Sichuan Prov, Peoples R China
[3] W China Med Ctr, Dept Gen Surg, Chengdu 610041, Sichuan Prov, Peoples R China
基金
中国国家自然科学基金;
关键词
methylation; imprinting; IGF2; H19; human hepatocellular carcinoma; liver;
D O I
10.1016/j.ygeno.2008.01.007
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
In this study, 39 human hepatocellular carcinoma (HCC) tissues and 7 normal adult liver tissues were screened for heterozygous polymorphisms in IGF2, H19, and the differentially methylated region of H19 (H19DMR) using PCR-RFLP and PCR sequencing. The imprinting of IGF2 and H19 was examined by RT-PCR-RFLP, while the methylation profile of H19DMR was detected by bisulfite sequencing from every informative sample. Of the informative HCC samples 47.06% (8 of 17) demonstrated a gain of imprinting of IGF2, and 21.74% (5 of 23) of the informative HCC samples demonstrated a loss of imprinting of H19. Interestingly, we found three methylation profiles for H19DMR in the informative HCC samples: hyper-, medium-, and hypomethylated profiles. Furthermore, the hypomethylated and hypermethylated profiles were immediately associated with aberrant imprinting of IGF2 and H19. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:443 / 450
页数:8
相关论文
共 37 条
[1]  
[Anonymous], 2001, Anal Biochem
[2]   Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene [J].
Bell, AC ;
Felsenfeld, G .
NATURE, 2000, 405 (6785) :482-485
[3]   THE PRODUCT OF THE H19 GENE MAY FUNCTION AS AN RNA [J].
BRANNAN, CI ;
DEES, EC ;
INGRAM, RS ;
TILGHMAN, SM .
MOLECULAR AND CELLULAR BIOLOGY, 1990, 10 (01) :28-36
[4]  
Cui HM, 2001, CANCER RES, V61, P4947
[5]  
Cui HM, 2002, CANCER RES, V62, P6442
[6]   A GROWTH-DEFICIENCY PHENOTYPE IN HETEROZYGOUS MICE CARRYING AN INSULIN-LIKE GROWTH FACTOR-II GENE DISRUPTED BY TARGETING [J].
DECHIARA, TM ;
EFSTRATIADIS, A ;
ROBERTSON, EJ .
NATURE, 1990, 345 (6270) :78-80
[7]   PARENTAL IMPRINTING OF THE MOUSE INSULIN-LIKE GROWTH FACTOR-II GENE [J].
DECHIARA, TM ;
ROBERTSON, EJ ;
EFSTRATIADIS, A .
CELL, 1991, 64 (04) :849-859
[8]  
Drewell RA, 2000, DEVELOPMENT, V127, P3419
[9]   Methylation-dependent silencing at the H19 imprinting control region by MeCP2 [J].
Drewell, RA ;
Goddard, CJ ;
Thomas, JO ;
Surani, MA .
NUCLEIC ACIDS RESEARCH, 2002, 30 (05) :1139-1144
[10]   Antagonism between DNA hypermethylation and enhancer-blocking activity at the H19 DMD is uncovered by CpG mutations [J].
Engel, N ;
West, AG ;
Felsenfeld, G ;
Bartolomei, MS .
NATURE GENETICS, 2004, 36 (08) :883-888